MissionIR Articles
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Featured in Dougherty & Company LLC Research Report
Trxade Group (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We are initiating coverage of Trxade with a Buy rating and Price Target of…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Engagement of MZ Group to Expand Strategic Communications Program Across Key Markets
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced its engagement of international investor relations specialists MZ Group (“MZ”) to expand its comprehensive strategic investor relations and financial communications…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Enters First Agreement to Supply COVID-19 Testing Kits
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced entry into its first Covid-19 antibody testing kits supply agreement with law firm McIntyre Thanasides Bringgold Elliott Grimaldi Guito &…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Enabling Patients to Access Physicians from Home
Trxade Group’s (NASDAQ: MEDS) wholly owned subsidiary Bonum Health is a virtual telehealth provider that is helping patients to simply and affordably access board-certified physicians and receive medical prescriptions from the comfort of their homes.…
-
Trxade Group Inc.’s (NASDAQ: MEDS) E-Commerce Platform Targeting Independent Pharmacy Market of Over $78 Billion a Year
Company boasts significant first-mover advantage in proprietary web-based e-commerce platform segment Revenue growth driven by increases in the number of registered users and acquisition of Pharmacy Currently adding 100+ pharmacies per month to its online…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Reaches Thousands of Independent Pharmacies with e-Commerce Platform
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, has more than 12,100 pharmacies currently registered as users…
-
Trxade Group Inc. (NASDAQ: MEDS) Reports Revenue Growth Amid Buildup to Multi-Platform Telehealth Integration
Trxade Group Inc. is an expanding healthcare tech platform builder that aims to assist small, community-based pharmaceutical businesses and the patients who comprise their customers through drug pricing and delivery operations as well as telemedicine…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) to Hold 2020 Annual Meeting of Stockholders on May 29
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, on Thursday announced that it will be holding its 2020 Annual Meeting of Stockholders at its corporate offices in Land O’ Lakes, Florida…
-
Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Bonum Health Offers Key Technology in Fight Against Coronavirus
Trxade Group’s wholly owned subsidiary, Bonum Health, allows patients to access medical advice from the comfort of their homes Telemedicine is getting its moment in the clinical spotlight as COVID-19 contagion fears are being addressed…
-
MissionIRNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Integra Pharma Solutions Files for FDA Emergency Use Authorization for Rapid COVID-19 Test Kit
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that its wholly-owned subsidiary, Integra Pharma Solutions, has filed for an Emergency Use Authorization (“EUA”) with the U.S. Food and…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces 2019 Annual Results
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, today announced annual results for the year…
-
MissionIRNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Subsidiary Bonum Health Offers Virtual Care Solution During Nationwide Crisis
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform has developed an affordable safety-first healthcare option for the 27.5 million uninsured Americans through its virtual care platform. This cost-effective option may…
-
Trxade Group Inc. (NASDAQ: MEDS) Has Over 11,900 Pharmacies on Trading Platform, with No Contract or Fee Obligations
Major first-mover advantage in proprietary web-based e-commerce platform segment Penetrating U.S. independent pharmacy market with total purchases of $92 billion per annum Adding 100+ pharmacies per month to its online purchasing platform Trxade Group Inc.…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Heightens Visibility via Nasdaq Listing
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform, recently announced its uplisting to the Nasdaq Capital Market and rang the opening bell on Friday, Feb. 28, 2020. An article discussing the company…
-
Trxade Group Inc. (NASDAQ: MEDS) Subsidiaries’ Visionary Telehealth Services Help Limit Impact of Global Viruses
Pioneering supplier-to-pharmacy tech platform builder Trxade Group Inc. helps small, community-based pharmaceutical businesses be competitive with larger chains by sourcing drugs at discount prices and promoting transparency in business operations Trxade Group has been developing…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces New Membership Service by Bonum Health and DelivMeds Subsidiaries
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced the onset of a new membership service by its subsidiaries Bonum Health and DelivMeds. According to the update, the monthly…
-
Trxade Group Inc. (NASDAQ: MEDS) Captures Significant Independent Pharmacy Market Share and Continues Steady Growth in 2020
Trxade Group has captured nearly half of the independent pharmacy market with its web-based purchasing platform “E-Bay/Kayak-like” Supplier-to-Pharmacy trading platform improves transaction processing between independent pharmacists and drug distributors Predictive data analytics features, price visibility…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) to Exhibit at HIMSS 2020 Global Health Conference & Exhibition
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables drug availability, care services and price transparency for both pharmacists and consumers, today announced that it will exhibit at HIMSS 2020.…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) CEO Rings Nasdaq Opening Bell
Trxade Group (NASDAQ: MEDS) announced that the company’s chief executive officer Suren Ajjarapu will ring the Nasdaq opening bell at 9:30 AM ET on February 28, 2020, signifying the start of trade. Trxade Group is…
-
Trxade Group Inc. (NASDAQ: MEDS) to Celebrate Nasdaq Uplisting with Opening Bell on Friday
Pharmaceutical services business Trxade Group Inc. recently announced its uplisting to the Nasdaq Capital Market and will ring the exchange’s opening bell this Friday, February 28, 2020 The ringing of the opening bell will be…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Pivotal Moment on Path to 2026 Rare Earth Oxide Production
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Marks Bold Entry Into the Growing Battery Storage Market with 4.99 MW BESS in Ontario
- Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy
- New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Eyes Bolivia’s Untapped Silver Potential Amid Global Supply Gaps
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial